Capricor Therapeutics (CAPR) Tops Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Capricor Therapeutics (CAPR) Tops Q2 EPS by 7c

Capricor Therapeutics Reports Second Quarter 2015 Business & Financial Highlights

August 13, 2015 4:05 PM EDT

LOS ANGELES, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today provided a business and financial update for the second quarter ended June 30, 2015.

Second Quarter and Recent Operational Highlights

Received FDA clearance for the HOPE-DUCHENNE Phase I/II trial of cardiosphere derived cell therapy, CAP-1002, for the treatment of Duchenne muscular dystrophy... More

Capricor Therapeutics Reports Second Quarter 2015 Business & Financial Highlights

August 13, 2015 4:05 PM EDT

LOS ANGELES, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today provided a business and financial update for the second quarter ended June 30, 2015.

Second Quarter and Recent Operational Highlights

Received FDA clearance for the HOPE-DUCHENNE Phase I/II trial of cardiosphere derived cell therapy, CAP-1002, for the treatment of Duchenne muscular dystrophy... More